Open AccessTuina for diabetes with obesity
Author(s) -
Sihan Peng,
Ziyan Xie,
Xiyu Zhang,
Ya Liu,
Xiangeng Zhang,
Xuezheng Liang,
Hongyan Wang,
Changchun Xie
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000023918
Subject(s) - medicine , cochrane library , diabetes mellitus , meta analysis , medline , randomized controlled trial , obesity , clinical trial , management of obesity , subgroup analysis , weight loss , political science , law , endocrinology
Background: Obesity is an independent risk factor for the occurrence and development of diabetes. Patients with diabetes combined with obesity will face serious burdens such as increase in insulin resistance and difficulty in blood glucose control. As a safe, effective, economical, and simple intervention, Tuina is more acceptable to the public than drugs. The objective of this systematic evaluation and meta-analysis is to evaluate the efficacy and safety of Tuina for diabetes with obesity. Methods: We will search the following electronic databases: PubMed, Embase, Cochrane Library, Web of science, Chinese National Knowledge Infrastructure (CNKI), Sino Med, Wanfang, Chinese Clinical Trial Registry System, China Biomedical Literature Database (CBM). The time limit for retrieving studies is from establishment to November 2020 for each database. Randomized controlled clinical trials related to Tuina intervention on diabetes with obesity will be included. Data synthesis, sensitivity analysis, subgroup analysis as well as the assessment of bias risk will be conducted by using Stata V.13.0 and Review manager 5.3 software. Results: This study will provide a quantitative and standardized evaluation for the efficacy of Tuina therapy on diabetes with obesity. Conclusion: This systematic review and meta-analysis will provide the high-quality evidence of whether Tuina is an effective intervention for diabetes with obesity. Registration number: INPLASY2020110106.